Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Augmented Renal ClearanceCritically Ill
Interventions
DRUG

Iohexol

"Intravenous injection of 5 ml of iohexol (Omnipaque) to calculate the glomerular filtration rate (area under the curve).~Blood samples (2 ml) and urine (2 ml minimum) are to be collected for the determination of iohexol clearance at the following time points: pre-dose, 5 minutes, and 1, 2, 3, 4, 5, 6 hours post dose."

Trial Locations (1)

75010

RECRUITING

Lariboisière Hospital, Surgical ICU, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER